Clinical Trial Update: Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dichloroacetate (DCA) for glioblastoma multiforme; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Dichloroacetate (DCA) (dichloroacetate)

Snippet

Sponsor: University of Florida | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING